Child Support System Replatforming

August 9, 2018

Share this Flipbook
Facebook
Twitter
Email
LinkedIn

Not sure of the best way to modernize your child support system? Many of the available approaches to modernization, like new system development, require tens of millions of dollars -- and a planning, procurement and delivery cycle that can last more than seven years. But replatforming can deliver a modernized system with less cost and less risk. We can help you streamline your modernization plan to realize the benefits of new technology while delivering crucial child support program functionality without interruption.

Previous Flipbook

Improvement to Family Support Program’s response rate

Conduent worked with an existing customer to put a process in place to field thousands of citizen phone cal...

Focusing on Families For Child Support Awareness Month 2018

August is officially recognized as Child Support Awareness Month.

Other content in this Stream

August 2020 Clinical Watch Newsletter

Child Support System Replatforming

Previous Flipbook

Next Article

Other content in this Stream

In this issue of Clinical Watch, we discuss new antipsychotic medication formulations to tailor the management of schizophrenia and suggest prior authorization criteria for a new treatment for Cushing

Conduent can help states to swiftly and seamlessly implement their Electronic Visit Verification EVV Program. Learn how.

In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and suggest prior authorization criteria for a new treatment for heavy menstrual bleeding

In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofi

In this issue of Clinical Watch, we highlight the NIH Panel recommendations regarding medications associated with COVID-19 treatment and suggest prior authorization criteria for the first approved tre

In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug.